查血液和玻璃体,寻找与增殖性糖尿病视网膜病变相关的生物标志物
Stephen Richard1, Rawan Kharouba2, Jawad Abu-Dbai2
1The Krieger Eye Research Laboratory, Bruce and Ruth Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3525433, Israel.
Diagnostics (Basel, Switzerland)
|June 13, 2025
概括
这项研究发现,在增殖性糖尿病视网膜病变 (PDR) 患者的玻璃体中,ANGPT2和VEGFA的mRNA表达增加. 血液样本显示HIF2A,PAI-1和ANGPT2的表达减少,这表明潜在的新治疗点.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 扩散性糖尿病视网膜病变 (PDR) 是糖尿病的严重并发症,导致视力丧失.
- 一些PDR患者对当前的治疗方法如抗VEGF注射或激光疗法没有反应.
- 识别新生物标志物对于开发替代治疗策略至关重要.
研究的目的:
- 在患有严重PDR的患者的玻璃体和血液中研究潜在的mRNA生物标志物.
- 为了比较PDR患者和健康对照者之间的基因表达特征.
- 在不响应PDR病例中探索针对性治疗的新途径.
主要方法:
- 从PDR患者和对照组收集了玻璃体和血液样本.
- 实时定量聚合酶连锁反应 (qPCR) 用于分析mRNA表达水平.
- 测量了包括HIF2A,PAI-1,TIE1,TIE2,ANGPT2和VEGFA在内的关键基因.
主要成果:
- 来自PDR患者的玻璃体样本显示,所有检查的基因,特别是ANGPT2和VEGFA的mRNA表达增加的趋势.
- 来自PDR患者的血液样本显示HIF2A,PAI-1和ANGPT2.2的mRNA表达减少的趋势.
- 维格法mRNA表达显示PDR血液样本的增加趋势,但不是显著的.
结论:
- 增加的ANGPT2和VEGFA玻璃体mRNA水平表明它们在PDR病变发生过程中的潜在作用.
- 血液中HIF2A,PAI-1和ANGPT2的mRNA水平降低需要进一步研究作为潜在的生物标志物.
- 这些发现强调了需要进行更大规模的队列研究来验证这些趋势,并探索PDR的新疗法目标.
相关概念视频
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...


